GlassScriptPhysician profile
Vicki Gasca
NPI 1316562408
$2,153.10
in general payments reported to CMS, 2019-2025
10 companies · $640 in 2025
The $640 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.90 · 2021: $185 · 2022: $256 · 2023: $246 · 2024: $798 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,683.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $563.78 | 2022-2025 | Infuse, Biotrue One Day, Xiidra |
| Coopervision INC. | $497.30 | 2021-2025 | Myday Contact Lens, Clariti Contact Lens, Biofinity Contact Lens |
| Alcon Vision LLC | $311.70 | 2022-2025 | Total30, Precision 1, Dailies Total1 |
| Sun Pharmaceutical Industries INC. | $299.42 | 2021-2025 | |
| Harrow Eye, LLC | $210.43 | 2024-2025 | Vevye |
| Johnson & Johnson Vision Care, INC. | $108.85 | 2025 | Acuvue |
| Sight Sciences, INC. | $54.69 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $48.70 | 2025 | Xdemvy |
| Abbvie INC. | $30.33 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $27.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicki Gasca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.